Concepts (324)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin D | 25 | 2018 | 186 | 3.140 |
Why?
|
| Vitamin D Deficiency | 17 | 2018 | 87 | 2.360 |
Why?
|
| Obesity | 29 | 2020 | 1111 | 2.150 |
Why?
|
| Aging | 26 | 2020 | 943 | 2.070 |
Why?
|
| Weight Loss | 14 | 2020 | 410 | 1.710 |
Why?
|
| Body Composition | 19 | 2020 | 327 | 1.700 |
Why?
|
| Mobility Limitation | 7 | 2017 | 208 | 1.330 |
Why?
|
| Aged | 76 | 2020 | 10259 | 1.280 |
Why?
|
| Overweight | 6 | 2018 | 252 | 1.130 |
Why?
|
| Life Style | 8 | 2020 | 394 | 1.120 |
Why?
|
| Dietary Proteins | 8 | 2020 | 63 | 1.120 |
Why?
|
| European Continental Ancestry Group | 26 | 2018 | 1076 | 1.080 |
Why?
|
| Body Mass Index | 24 | 2019 | 863 | 1.080 |
Why?
|
| Exercise | 7 | 2019 | 605 | 1.070 |
Why?
|
| Physical Fitness | 5 | 2012 | 120 | 1.030 |
Why?
|
| Polymorphism, Single Nucleotide | 21 | 2018 | 1052 | 1.010 |
Why?
|
| Female | 81 | 2020 | 19969 | 0.980 |
Why?
|
| Male | 78 | 2020 | 19456 | 0.970 |
Why?
|
| Caloric Restriction | 4 | 2019 | 92 | 0.940 |
Why?
|
| Diet | 7 | 2020 | 383 | 0.920 |
Why?
|
| Humans | 93 | 2020 | 32323 | 0.840 |
Why?
|
| Prospective Studies | 25 | 2020 | 2319 | 0.750 |
Why?
|
| Accidental Falls | 4 | 2019 | 104 | 0.740 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2018 | 1438 | 0.710 |
Why?
|
| Independent Living | 5 | 2020 | 90 | 0.710 |
Why?
|
| Eating | 3 | 2017 | 77 | 0.700 |
Why?
|
| Muscle Strength | 7 | 2020 | 136 | 0.680 |
Why?
|
| Motor Activity | 6 | 2015 | 332 | 0.650 |
Why?
|
| Genome-Wide Association Study | 15 | 2018 | 543 | 0.640 |
Why?
|
| Longevity | 1 | 2020 | 23 | 0.630 |
Why?
|
| Parathyroid Hormone | 5 | 2012 | 45 | 0.610 |
Why?
|
| Dietary Supplements | 6 | 2018 | 189 | 0.590 |
Why?
|
| African Continental Ancestry Group | 10 | 2018 | 338 | 0.580 |
Why?
|
| Disabled Persons | 2 | 2012 | 100 | 0.560 |
Why?
|
| Pennsylvania | 8 | 2018 | 80 | 0.520 |
Why?
|
| Tennessee | 8 | 2018 | 101 | 0.520 |
Why?
|
| Middle Aged | 31 | 2020 | 11848 | 0.500 |
Why?
|
| Amino Acids | 1 | 2017 | 52 | 0.500 |
Why?
|
| Body Weight | 7 | 2020 | 323 | 0.500 |
Why?
|
| Follow-Up Studies | 14 | 2019 | 2238 | 0.490 |
Why?
|
| Vitamins | 3 | 2015 | 70 | 0.480 |
Why?
|
| Nutrition Policy | 3 | 2020 | 31 | 0.480 |
Why?
|
| Muscle, Skeletal | 7 | 2019 | 520 | 0.470 |
Why?
|
| Homebound Persons | 1 | 2015 | 9 | 0.450 |
Why?
|
| Cholecalciferol | 1 | 2015 | 25 | 0.450 |
Why?
|
| Food Services | 1 | 2015 | 19 | 0.450 |
Why?
|
| Cohort Studies | 19 | 2018 | 1840 | 0.440 |
Why?
|
| Behavior Therapy | 1 | 2014 | 103 | 0.410 |
Why?
|
| Health Status | 8 | 2018 | 356 | 0.410 |
Why?
|
| Blood Glucose | 7 | 2019 | 484 | 0.390 |
Why?
|
| African Americans | 9 | 2018 | 1335 | 0.390 |
Why?
|
| Aged, 80 and over | 15 | 2020 | 3899 | 0.390 |
Why?
|
| Activities of Daily Living | 5 | 2014 | 246 | 0.380 |
Why?
|
| Feeding Behavior | 4 | 2017 | 154 | 0.370 |
Why?
|
| Genetic Loci | 6 | 2018 | 143 | 0.370 |
Why?
|
| Cross-Sectional Studies | 12 | 2018 | 1485 | 0.360 |
Why?
|
| Risk Factors | 18 | 2019 | 3940 | 0.360 |
Why?
|
| Proportional Hazards Models | 7 | 2014 | 773 | 0.360 |
Why?
|
| Dairy Products | 2 | 2017 | 13 | 0.360 |
Why?
|
| Incidence | 11 | 2019 | 1244 | 0.350 |
Why?
|
| Geriatric Assessment | 9 | 2019 | 335 | 0.350 |
Why?
|
| Depression | 1 | 2014 | 427 | 0.340 |
Why?
|
| Nutritional Status | 4 | 2014 | 73 | 0.340 |
Why?
|
| Insulin | 4 | 2015 | 359 | 0.330 |
Why?
|
| Hand Strength | 4 | 2018 | 98 | 0.330 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2019 | 548 | 0.320 |
Why?
|
| Energy Intake | 7 | 2019 | 122 | 0.310 |
Why?
|
| Diet, Reducing | 4 | 2019 | 85 | 0.300 |
Why?
|
| Mortality | 4 | 2015 | 122 | 0.300 |
Why?
|
| Diet Surveys | 5 | 2019 | 48 | 0.300 |
Why?
|
| United States | 16 | 2019 | 4079 | 0.300 |
Why?
|
| Sarcopenia | 3 | 2019 | 50 | 0.290 |
Why?
|
| Retirement | 1 | 2008 | 13 | 0.280 |
Why?
|
| Linear Models | 7 | 2018 | 426 | 0.270 |
Why?
|
| Bone Density | 2 | 2019 | 169 | 0.270 |
Why?
|
| Cognition | 4 | 2016 | 549 | 0.260 |
Why?
|
| Diabetes Mellitus | 2 | 2008 | 390 | 0.260 |
Why?
|
| Muscular Atrophy | 1 | 2008 | 74 | 0.260 |
Why?
|
| Heart Diseases | 2 | 2018 | 114 | 0.260 |
Why?
|
| Longitudinal Studies | 7 | 2018 | 760 | 0.250 |
Why?
|
| Genotype | 8 | 2018 | 706 | 0.250 |
Why?
|
| Nutrition Assessment | 4 | 2011 | 48 | 0.250 |
Why?
|
| Gait | 3 | 2013 | 120 | 0.240 |
Why?
|
| Adult | 16 | 2018 | 9267 | 0.240 |
Why?
|
| Vegetables | 2 | 2010 | 41 | 0.240 |
Why?
|
| Fruit | 2 | 2010 | 51 | 0.240 |
Why?
|
| Ethnic Groups | 3 | 2017 | 450 | 0.230 |
Why?
|
| Pilot Projects | 2 | 2019 | 555 | 0.230 |
Why?
|
| Proteins | 3 | 2020 | 149 | 0.220 |
Why?
|
| Sex Factors | 7 | 2020 | 656 | 0.220 |
Why?
|
| Lung | 2 | 2018 | 263 | 0.210 |
Why?
|
| Thinness | 2 | 2015 | 32 | 0.200 |
Why?
|
| Confidence Intervals | 3 | 2009 | 141 | 0.200 |
Why?
|
| Diet, Mediterranean | 2 | 2014 | 31 | 0.190 |
Why?
|
| Cognition Disorders | 3 | 2014 | 349 | 0.190 |
Why?
|
| Alleles | 5 | 2014 | 250 | 0.190 |
Why?
|
| Adipose Tissue | 3 | 2011 | 319 | 0.180 |
Why?
|
| Osteoporosis | 2 | 2019 | 51 | 0.180 |
Why?
|
| Meat | 2 | 2015 | 17 | 0.180 |
Why?
|
| Frail Elderly | 2 | 2019 | 69 | 0.170 |
Why?
|
| Thigh | 2 | 2019 | 35 | 0.170 |
Why?
|
| Respiratory Function Tests | 2 | 2018 | 93 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2018 | 821 | 0.160 |
Why?
|
| Nutritional Sciences | 1 | 2020 | 6 | 0.160 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2020 | 16 | 0.160 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2019 | 9 | 0.150 |
Why?
|
| Risk Assessment | 5 | 2018 | 1424 | 0.150 |
Why?
|
| Soft Tissue Injuries | 1 | 2019 | 18 | 0.150 |
Why?
|
| Chronic Disease | 2 | 2012 | 411 | 0.150 |
Why?
|
| Chi-Square Distribution | 4 | 2012 | 287 | 0.150 |
Why?
|
| Dietary Fats | 3 | 2014 | 99 | 0.140 |
Why?
|
| Age Factors | 5 | 2018 | 1179 | 0.140 |
Why?
|
| Disability Evaluation | 3 | 2019 | 241 | 0.140 |
Why?
|
| Vitamin K | 1 | 2018 | 8 | 0.140 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 312 | 0.140 |
Why?
|
| Random Allocation | 1 | 2019 | 247 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2019 | 91 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2018 | 50 | 0.140 |
Why?
|
| Inflammation | 2 | 2012 | 507 | 0.140 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 12 | 0.140 |
Why?
|
| Seafood | 1 | 2017 | 10 | 0.130 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 33 | 0.130 |
Why?
|
| Docosahexaenoic Acids | 1 | 2017 | 25 | 0.130 |
Why?
|
| Osteoarthritis, Knee | 1 | 2018 | 71 | 0.130 |
Why?
|
| Absorptiometry, Photon | 4 | 2014 | 98 | 0.130 |
Why?
|
| Appetite | 1 | 2017 | 23 | 0.130 |
Why?
|
| Genome, Human | 2 | 2018 | 130 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 180 | 0.130 |
Why?
|
| Heart | 1 | 2018 | 177 | 0.130 |
Why?
|
| Walking | 3 | 2013 | 199 | 0.130 |
Why?
|
| Lower Extremity | 1 | 2018 | 99 | 0.130 |
Why?
|
| Genetics, Population | 1 | 2017 | 31 | 0.130 |
Why?
|
| Urinary Incontinence | 1 | 2017 | 68 | 0.130 |
Why?
|
| Exercise Therapy | 2 | 2019 | 249 | 0.120 |
Why?
|
| Dietary Carbohydrates | 2 | 2014 | 21 | 0.120 |
Why?
|
| Prevalence | 4 | 2018 | 960 | 0.120 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2014 | 18 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2018 | 243 | 0.120 |
Why?
|
| Odds Ratio | 4 | 2017 | 455 | 0.120 |
Why?
|
| Health Behavior | 3 | 2014 | 213 | 0.120 |
Why?
|
| Time Factors | 5 | 2015 | 2204 | 0.120 |
Why?
|
| Meat Products | 1 | 2015 | 3 | 0.120 |
Why?
|
| Hyperinsulinism | 1 | 2015 | 13 | 0.110 |
Why?
|
| Phenotype | 5 | 2015 | 623 | 0.110 |
Why?
|
| Hip Fractures | 2 | 2012 | 26 | 0.110 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 49 | 0.110 |
Why?
|
| Epistasis, Genetic | 1 | 2015 | 43 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2015 | 85 | 0.110 |
Why?
|
| Single-Blind Method | 1 | 2015 | 192 | 0.110 |
Why?
|
| Stroke Volume | 1 | 2018 | 417 | 0.110 |
Why?
|
| Coffea | 1 | 2014 | 1 | 0.110 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2014 | 9 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2015 | 309 | 0.110 |
Why?
|
| Antidepressive Agents | 1 | 2014 | 73 | 0.100 |
Why?
|
| Hearing Loss | 1 | 2014 | 25 | 0.100 |
Why?
|
| Health Surveys | 2 | 2011 | 175 | 0.100 |
Why?
|
| Genetic Variation | 2 | 2012 | 253 | 0.100 |
Why?
|
| Apolipoprotein E4 | 1 | 2014 | 56 | 0.100 |
Why?
|
| Adiposity | 2 | 2012 | 190 | 0.100 |
Why?
|
| Fasting | 2 | 2012 | 88 | 0.100 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2013 | 12 | 0.100 |
Why?
|
| Muscle Weakness | 1 | 2014 | 34 | 0.100 |
Why?
|
| Health Education | 1 | 2014 | 149 | 0.100 |
Why?
|
| Nutrition Surveys | 5 | 2013 | 144 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 880 | 0.100 |
Why?
|
| Homozygote | 2 | 2010 | 52 | 0.100 |
Why?
|
| PPAR gamma | 2 | 2011 | 51 | 0.100 |
Why?
|
| Calcium, Dietary | 1 | 2013 | 21 | 0.100 |
Why?
|
| Trace Elements | 1 | 2013 | 6 | 0.100 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 21 | 0.090 |
Why?
|
| Magnesium | 1 | 2013 | 29 | 0.090 |
Why?
|
| Lipoprotein Lipase | 1 | 2012 | 13 | 0.090 |
Why?
|
| Receptors, Calcitriol | 1 | 2012 | 13 | 0.090 |
Why?
|
| Hyperparathyroidism | 1 | 2012 | 9 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2015 | 458 | 0.090 |
Why?
|
| Seasons | 4 | 2015 | 74 | 0.090 |
Why?
|
| Gene Frequency | 3 | 2018 | 212 | 0.090 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2012 | 5 | 0.090 |
Why?
|
| Homeostasis | 1 | 2012 | 130 | 0.090 |
Why?
|
| Linkage Disequilibrium | 4 | 2013 | 181 | 0.090 |
Why?
|
| Urban Population | 1 | 2012 | 91 | 0.090 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 388 | 0.090 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2012 | 52 | 0.090 |
Why?
|
| Knee | 1 | 2011 | 27 | 0.090 |
Why?
|
| Heart Failure | 1 | 2018 | 728 | 0.090 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 22 | 0.090 |
Why?
|
| Pain Measurement | 1 | 2012 | 340 | 0.090 |
Why?
|
| Lipids | 1 | 2012 | 254 | 0.090 |
Why?
|
| Zinc | 1 | 2011 | 29 | 0.080 |
Why?
|
| Reference Values | 1 | 2011 | 238 | 0.080 |
Why?
|
| Calcium | 1 | 2013 | 339 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2018 | 859 | 0.080 |
Why?
|
| Anthropometry | 2 | 2014 | 89 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 110 | 0.080 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 46 | 0.080 |
Why?
|
| Quality of Life | 2 | 2019 | 971 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2012 | 181 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2012 | 144 | 0.080 |
Why?
|
| Resistance Training | 1 | 2011 | 59 | 0.080 |
Why?
|
| Body Fat Distribution | 1 | 2010 | 25 | 0.080 |
Why?
|
| Hypertension | 2 | 2014 | 983 | 0.080 |
Why?
|
| Europe | 3 | 2017 | 82 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 96 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 186 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2010 | 153 | 0.070 |
Why?
|
| Physical Endurance | 1 | 2008 | 40 | 0.070 |
Why?
|
| Age Distribution | 1 | 2009 | 194 | 0.070 |
Why?
|
| Health Status Disparities | 1 | 2009 | 128 | 0.070 |
Why?
|
| Oxygen Consumption | 2 | 2019 | 141 | 0.070 |
Why?
|
| Logistic Models | 2 | 2011 | 743 | 0.070 |
Why?
|
| Hospitalization | 1 | 2010 | 476 | 0.070 |
Why?
|
| Arteriosclerosis | 2 | 2005 | 147 | 0.060 |
Why?
|
| Patient Selection | 1 | 2008 | 272 | 0.060 |
Why?
|
| Exercise Test | 2 | 2019 | 218 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2007 | 174 | 0.060 |
Why?
|
| Atherosclerosis | 2 | 2013 | 826 | 0.060 |
Why?
|
| Forced Expiratory Volume | 2 | 2018 | 81 | 0.060 |
Why?
|
| Prognosis | 3 | 2018 | 1529 | 0.060 |
Why?
|
| Fibroblast Growth Factors | 2 | 2018 | 37 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1159 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2018 | 273 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 650 | 0.050 |
Why?
|
| Neuropsychological Tests | 2 | 2016 | 329 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2008 | 3613 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 69 | 0.050 |
Why?
|
| Quantitative Trait Loci | 2 | 2013 | 140 | 0.050 |
Why?
|
| Risk | 2 | 2014 | 305 | 0.050 |
Why?
|
| Dietary Fiber | 1 | 2002 | 20 | 0.050 |
Why?
|
| Cause of Death | 2 | 2012 | 236 | 0.040 |
Why?
|
| Biomass | 1 | 2020 | 4 | 0.040 |
Why?
|
| Abdominal Fat | 2 | 2011 | 39 | 0.040 |
Why?
|
| Smoking | 2 | 2018 | 505 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2011 | 121 | 0.040 |
Why?
|
| Subcutaneous Fat | 2 | 2011 | 43 | 0.040 |
Why?
|
| Muscle Development | 1 | 2020 | 52 | 0.040 |
Why?
|
| Muscles | 1 | 2020 | 69 | 0.040 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2019 | 8 | 0.040 |
Why?
|
| Maryland | 1 | 2019 | 27 | 0.040 |
Why?
|
| Hispanic Americans | 2 | 2018 | 772 | 0.040 |
Why?
|
| Residence Characteristics | 2 | 2012 | 179 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 716 | 0.040 |
Why?
|
| Tomography | 1 | 2019 | 5 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 2652 | 0.040 |
Why?
|
| Hip | 1 | 2019 | 14 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2011 | 478 | 0.040 |
Why?
|
| Fatigue | 1 | 2019 | 80 | 0.040 |
Why?
|
| Weight Gain | 1 | 2019 | 104 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 18 | 0.040 |
Why?
|
| Geriatrics | 1 | 2019 | 86 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2018 | 37 | 0.040 |
Why?
|
| Femur | 1 | 2019 | 74 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2018 | 8 | 0.040 |
Why?
|
| Lumbar Vertebrae | 1 | 2019 | 93 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 119 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 2018 | 9 | 0.030 |
Why?
|
| Health Services for the Aged | 1 | 2018 | 24 | 0.030 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2017 | 3 | 0.030 |
Why?
|
| Actins | 1 | 2017 | 55 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 46 | 0.030 |
Why?
|
| Genomics | 1 | 2018 | 90 | 0.030 |
Why?
|
| Posture | 1 | 2017 | 62 | 0.030 |
Why?
|
| Postural Balance | 1 | 2017 | 142 | 0.030 |
Why?
|
| Publication Bias | 1 | 2015 | 7 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 146 | 0.030 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2015 | 9 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 854 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 2 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 37 | 0.030 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2014 | 101 | 0.030 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Georgia | 1 | 2014 | 15 | 0.030 |
Why?
|
| Calcifediol | 1 | 2014 | 10 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 160 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2013 | 31 | 0.020 |
Why?
|
| Metagenomics | 1 | 2013 | 4 | 0.020 |
Why?
|
| North America | 1 | 2013 | 31 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 8 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 558 | 0.020 |
Why?
|
| Steroid Hydroxylases | 1 | 2012 | 2 | 0.020 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2012 | 5 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2013 | 137 | 0.020 |
Why?
|
| Medicare | 1 | 2014 | 218 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 47 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2012 | 124 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 188 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 80 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 181 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 108 | 0.020 |
Why?
|
| Triglycerides | 1 | 2012 | 235 | 0.020 |
Why?
|
| Child | 1 | 2018 | 2445 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 212 | 0.020 |
Why?
|
| Distance Perception | 1 | 2011 | 2 | 0.020 |
Why?
|
| Continental Population Groups | 1 | 2013 | 228 | 0.020 |
Why?
|
| Judgment | 1 | 2011 | 12 | 0.020 |
Why?
|
| Intention | 1 | 2011 | 30 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 471 | 0.020 |
Why?
|
| Arm | 1 | 2011 | 42 | 0.020 |
Why?
|
| Choristoma | 1 | 2011 | 14 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 221 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2010 | 10 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 108 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2010 | 24 | 0.020 |
Why?
|
| Immunoassay | 1 | 2010 | 16 | 0.020 |
Why?
|
| International Cooperation | 1 | 2010 | 31 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 478 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 3521 | 0.020 |
Why?
|
| Heterozygote | 1 | 2010 | 60 | 0.020 |
Why?
|
| Adipokines | 1 | 2010 | 11 | 0.020 |
Why?
|
| Canada | 1 | 2010 | 64 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2010 | 28 | 0.020 |
Why?
|
| Self Disclosure | 1 | 2010 | 21 | 0.020 |
Why?
|
| Water | 1 | 2010 | 65 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2010 | 63 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2009 | 91 | 0.020 |
Why?
|
| Baltimore | 1 | 2009 | 50 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 179 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 466 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 550 | 0.020 |
Why?
|
| Postmenopause | 1 | 2008 | 424 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 906 | 0.010 |
Why?
|
| Neoplasms | 1 | 2012 | 762 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2007 | 255 | 0.010 |
Why?
|
| North Carolina | 1 | 2002 | 1300 | 0.010 |
Why?
|